Search research articles
Contact Us
Filters
Showing results (131-140 of 193) with videos related to
Page
of 20
Sort By:
Journal of Medical Microbiology
|
May 6, 1998
Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice
T Matsumoto, K Tateda, S Miyazaki, et al.
Journal of Medical Microbiology
|
May 6, 1998
Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice
T Matsumoto, K Tateda, N Furuya, et al.
Antimicrobial Agents and Chemotherapy
|
July 14, 1998
In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic
S Tamura, S Miyazaki, K Tateda, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1997
Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice
T Matsumoto, K Tateda, S Miyazaki, et al.
Infection and Immunity
|
January 1, 1991
Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia
Y Hirakata, K Tomono, K Tateda, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
May 1, 1986
[Detection of antineutrophil autoantibodies with immunofluorescence test using flow cytometry]
K Saito, S Furusawa, A Okuyama, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
January 30, 2020
Amniocele after laparoscopic myomectomy: is expectant management acceptable?
K Ito, J Hasegawa, H Iwahata, et al.
Cytokine
|
November 5, 1997
Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis
T Matsumoto, K Tateda, S Miyazaki, et al.
Antimicrobial Agents and Chemotherapy
|
November 26, 1997
In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections
S Miyazaki, H Domon, K Tateda, et al.
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections
S Miyazaki, T Hosoyama, N Furuya, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 193) with videos related to
Sort By:
Page
of 20
Journal of Medical Microbiology
|
May 6, 1998
Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice
T Matsumoto, K Tateda, S Miyazaki, et al.
Journal of Medical Microbiology
|
May 6, 1998
Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice
T Matsumoto, K Tateda, N Furuya, et al.
Antimicrobial Agents and Chemotherapy
|
July 14, 1998
In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic
S Tamura, S Miyazaki, K Tateda, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1997
Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice
T Matsumoto, K Tateda, S Miyazaki, et al.
Infection and Immunity
|
January 1, 1991
Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia
Y Hirakata, K Tomono, K Tateda, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
May 1, 1986
[Detection of antineutrophil autoantibodies with immunofluorescence test using flow cytometry]
K Saito, S Furusawa, A Okuyama, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
January 30, 2020
Amniocele after laparoscopic myomectomy: is expectant management acceptable?
K Ito, J Hasegawa, H Iwahata, et al.
Cytokine
|
November 5, 1997
Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis
T Matsumoto, K Tateda, S Miyazaki, et al.
Antimicrobial Agents and Chemotherapy
|
November 26, 1997
In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections
S Miyazaki, H Domon, K Tateda, et al.
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections
S Miyazaki, T Hosoyama, N Furuya, et al.
Page
of 20